Applied Therapeutics, Inc. (APLT) Investors with Losses are Urged to Contact Levi & Korsinsky to Discuss Their Rights
Portfolio Pulse from
Levi & Korsinsky has initiated an investigation into Applied Therapeutics, Inc. (APLT) for potential federal securities law violations following an FDA Complete Response Letter regarding their drug govorestat.
December 13, 2024 | 3:45 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Applied Therapeutics is under investigation by Levi & Korsinsky for potential securities law violations after the FDA issued a Complete Response Letter for their drug govorestat.
The FDA's Complete Response Letter indicates significant regulatory hurdles for govorestat, impacting APLT's drug approval process. The investigation by Levi & Korsinsky suggests potential legal issues, likely affecting investor confidence and stock price negatively in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100